Breaking
Sunday, June 14, 2026

Regulatory Updates

🇺🇸 FDA Page 8

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.

Showing 85–96 of 382 articles

High impact AnalysisJun 4, 2026

FDA's Future: Insights from Former Commissioner David Kessler

FDA · 5 min

Dr. Sarah Mitchell
High impact NewsJun 4, 2026

Pharma in Focus: Regulatory Updates You Need to Know

FDA · 5 min

Dr. Sarah Mitchell
High impact AnalysisJun 4, 2026

Drug Discovery USA 2026: What to Expect

FDA · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 4, 2026

Kailera's Triple-G Drug: A Potential Game-Changer in Pharma

FDA · 5 min

Dr. Sarah Mitchell
Critical impact AnalysisJun 4, 2026

FDA Shakeup: Høeg's Departure and Amgen Drug Controversy

FDA · 5 min

Dr. Sarah Mitchell
High impact NewsJun 4, 2026

FDA Approves First Oral COVID-19 PEP Drug, Xocova

FDA · COVID-19 · 4 min

Dr. Sarah Mitchell
High impact AnalysisJun 4, 2026

Pfizer sharpens prostate cancer case with Talzenna win — oncology

oncology · 5 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

Explaining Unapproved Drugs to Payors: FDA Guidance Helps Pharma Avoid Pitfalls

FDA · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

AstraZeneca's Camizestrant: Navigating Divergent Regulatory Paths for Breast Cancer Treatment

FDA · breast cancer · 6 min

Dr. Sarah Mitchell
High impact NewsJun 3, 2026

FDA Blueprint Aims to Reduce Regulatory Risks for Animal Testing Alternatives

FDA · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

Why Optimistic Scientists Are Losing Heart: Insights from MIT

FDA · 6 min

Dr. Sarah Mitchell
High impact NewsJun 3, 2026

China’s Rise in Drug Development Looms Over U.S. Oncology Market

FDA · oncology · 5 min

Dr. Sarah Mitchell